drugset / Press release
Emergent BioSolutions Receives FDA Orphan Drug Status for BioThrax for Post-Exposure Prophylaxis of Anthrax Disease
2016-06-15 · Emergent BioSolutions · original emergentbiosolutions.com ↗
061516 - BioThrax PEP Orphan Drug Status FINAL.pdf 70.5 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗